Brief: Aadi Bioscience Announces Improved Anti-Tumor Activity Of KRAS Inhibitors In Combination With NAB-Sirolimus

Whitehawk Therapeutics

12/10/2022 13:02

Oct 12 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE ANNOUNCES IMPROVED ANTI-TUMOR ACTIVITY OF
KRAS
INHIBITORS IN COMBINATION WITH NAB-SIROLIMUS

Source text for Eikon:  ID:nPn23L0Mza 
Further company coverage:  AADI.O 
 ((Reuters.Briefs@thomsonreuters.com;))